An open-label, one-sequence cross-over study to investigate the effect of deferasirox on the pharmacokinetics of midazolam in healthy volunteers

Trial Profile

An open-label, one-sequence cross-over study to investigate the effect of deferasirox on the pharmacokinetics of midazolam in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Sep 2009

At a glance

  • Drugs Deferasirox; Midazolam
  • Indications Anxiety disorders; Seizures
  • Focus Pharmacokinetics
  • Sponsors Novartis
  • Most Recent Events

    • 29 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Feb 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top